205 related articles for article (PubMed ID: 37625781)
41. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.
De Sandre-Giovannoli A; Chaouch M; Kozlov S; Vallat JM; Tazir M; Kassouri N; Szepetowski P; Hammadouche T; Vandenberghe A; Stewart CL; Grid D; Lévy N
Am J Hum Genet; 2002 Mar; 70(3):726-36. PubMed ID: 11799477
[TBL] [Abstract][Full Text] [Related]
42. The shifting paradigm of Charcot-Marie-Tooth disease.
Echaniz-Laguna A
Rev Neurol (Paris); 2015; 171(6-7):498-504. PubMed ID: 25896909
[TBL] [Abstract][Full Text] [Related]
43. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
44. Exacerbation of Charcot-Marie-Tooth type 2E neuropathy following traumatic nerve injury.
Villalón E; Dale JM; Jones M; Shen H; Garcia ML
Brain Res; 2015 Nov; 1627():143-53. PubMed ID: 26423936
[TBL] [Abstract][Full Text] [Related]
45. A novel HSPB1 mutation in an Italian patient with CMT2/dHMN phenotype.
Luigetti M; Fabrizi GM; Madia F; Ferrarini M; Conte A; Del Grande A; Tasca G; Tonali PA; Sabatelli M
J Neurol Sci; 2010 Nov; 298(1-2):114-7. PubMed ID: 20870250
[TBL] [Abstract][Full Text] [Related]
46. Mitochondrial dynamics and inherited peripheral nerve diseases.
Pareyson D; Saveri P; Sagnelli A; Piscosquito G
Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
[TBL] [Abstract][Full Text] [Related]
47. Genetic and Clinical Studies of Peripheral Neuropathies with Three Small Heat Shock Protein Gene Variants in Korea.
Lim SO; Jung NY; Lee AJ; Choi HJ; Kwon HM; Son W; Nam SH; Choi BO; Chung KW
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328016
[TBL] [Abstract][Full Text] [Related]
48. [From gene to disease; Charcot-Marie-Tooth disease or the hereditary motor and sensory neuropathies].
Verhamme C; Baas F
Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1505-9. PubMed ID: 16032995
[TBL] [Abstract][Full Text] [Related]
49. Mutations in HspB1 and hereditary neuropathies.
Muranova LK; Sudnitsyna MV; Strelkov SV; Gusev NB
Cell Stress Chaperones; 2020 Jul; 25(4):655-665. PubMed ID: 32301006
[TBL] [Abstract][Full Text] [Related]
50. Early-onset axonal Charcot-Marie-Tooth disease due to SACS mutation.
Souza PVS; Bortholin T; Naylor FGM; Pinto WBVR; Oliveira ASB
Neuromuscul Disord; 2018 Feb; 28(2):169-172. PubMed ID: 29277257
[TBL] [Abstract][Full Text] [Related]
51. Mitochondrial deficits and abnormal mitochondrial retrograde axonal transport play a role in the pathogenesis of mutant Hsp27-induced Charcot Marie Tooth Disease.
Kalmar B; Innes A; Wanisch K; Kolaszynska AK; Pandraud A; Kelly G; Abramov AY; Reilly MM; Schiavo G; Greensmith L
Hum Mol Genet; 2017 Sep; 26(17):3313-3326. PubMed ID: 28595321
[TBL] [Abstract][Full Text] [Related]
52. Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy.
Solla P; Vannelli A; Bolino A; Marrosu G; Coviello S; Murru MR; Tranquilli S; Corongiu D; Benedetti S; Marrosu MG
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):958-62. PubMed ID: 20660910
[TBL] [Abstract][Full Text] [Related]
53. Genetic evaluation of inherited motor/sensory neuropathy.
Chance PF
Suppl Clin Neurophysiol; 2004; 57():228-42. PubMed ID: 16106622
[TBL] [Abstract][Full Text] [Related]
54. A novel mouse model carrying a human cytoplasmic dynein mutation shows motor behavior deficits consistent with Charcot-Marie-Tooth type 2O disease.
Sabblah TT; Nandini S; Ledray AP; Pasos J; Calderon JLC; Love R; King LE; King SJ
Sci Rep; 2018 Jan; 8(1):1739. PubMed ID: 29379136
[TBL] [Abstract][Full Text] [Related]
55. Targeted next-generation sequencing reveals further genetic heterogeneity in axonal Charcot-Marie-Tooth neuropathy and a mutation in HSPB1.
Ylikallio E; Johari M; Konovalova S; Moilanen JS; Kiuru-Enari S; Auranen M; Pajunen L; Tyynismaa H
Eur J Hum Genet; 2014 Apr; 22(4):522-7. PubMed ID: 23963299
[TBL] [Abstract][Full Text] [Related]
56. Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease.
Benoy V; Vanden Berghe P; Jarpe M; Van Damme P; Robberecht W; Van Den Bosch L
Neurotherapeutics; 2017 Apr; 14(2):417-428. PubMed ID: 27957719
[TBL] [Abstract][Full Text] [Related]
57. [Distal hereditary motor neuropathy type II with mutation in heat shock protein 27 gene. A case report].
Nishibayashi M; Kokubun N; Nakamura A; Hirata K; Yamamoto M; Sobue G
Rinsho Shinkeigaku; 2007 Jan; 47(1):50-2. PubMed ID: 17491338
[TBL] [Abstract][Full Text] [Related]
58. A novel p.Gln175X [corrected] premature stop mutation in the C-terminal end of HSP27 is a cause of CMT2.
Rossor AM; Davidson GL; Blake J; Polke JM; Murphy SM; Houlden H; Innes A; Kalmar B; Greensmith L; Reilly MM
J Peripher Nerv Syst; 2012 Jun; 17(2):201-5. PubMed ID: 22734906
[TBL] [Abstract][Full Text] [Related]
59. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
